Skip to main content
Clinical Trials/NCT03068156
NCT03068156CompletedNot Applicable

Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study

Chulalongkorn University1 site in 1 country15 target enrollmentStarted: January 31, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
Roughness evaluation by using Visioscan® VC98

Study Overview

Brief Summary

Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients, aged >18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathologic features

Exclusion Criteria

  • •Those with cutaneous amyloidosis associated systemic diseases
  • •Pregnancy or lactating woman
  • •Those who are allergic to urea, olive oil
  • •Those who are photosensitive to ultraviolet radiation
  • •Those who had been previously treated with medications/ radiation/ laser within 3 months for systemic and 1 month for topical therapy

Arms & Interventions

excimer laser

Experimental

Intervention: 308-nm excimer laser (Radiation)

Control

No Intervention

Outcomes

Primary Outcomes

Roughness evaluation by using Visioscan® VC98

Time Frame: Change from baseline roughness at every 2 weeks up to 16 weeks

The improvement of roughness evaluation

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Einapak Boontaveeyuwat, MD

Asst. Prof.

Chulalongkorn University

Study Sites (1)

Loading locations...

Similar Trials